MedPath

A study for evaluating the effect of suppressing of blood glucose level after meals of the intake of food containing HYA on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000028509
Lead Sponsor
TTC Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who routinely use health food containing large amount of unsaturated fatty acids or health food for diet 2) Subjects routinely taking medicine or health food which may influence glucose metabolism 3) Subjects who have body mass index (BMI) less than 18.5 kg/square meter or more than 30.0 kg/square meter 4) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination 5) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 6) Subjects having possibilities for emerging allergy related to the current study 7) Subjects who are under medication or having a history of serious diseases for which medication was required 8) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination 9) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 10) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 12) Subjects judged as unsuitable for the study by the investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the curve of plasma glucose levels
Secondary Outcome Measures
NameTimeMethod
Postprandial blood glucose, maximum plasma glucose levels, postprandial insulin levels
© Copyright 2025. All Rights Reserved by MedPath